Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?

Papillary renal cell carcinoma (pRCC) represents the second most common subtype of renal cell carcinoma, following clear cell carcinoma and accounting for 10–15% of cases. For around 20 years, pRCCs have been classified according to their mere histopathologic appearance, unsupported by genetic and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Trevisani, Francesco, Floris, Matteo, Vago, Riccardo, Minnei, Roberto, Cinque, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139553/
https://www.ncbi.nlm.nih.gov/pubmed/35626699
http://dx.doi.org/10.3390/cells11101658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139553/
https://www.ncbi.nlm.nih.gov/pubmed/35626699
http://dx.doi.org/10.3390/cells11101658

Ejemplares similares